Table 1. Details of MPN patient samples used in this study.
Patient ID | Age/sex | Mutation | Platelets (K/µl) | Disease |
---|---|---|---|---|
5502-1 | 44/F | CRT 52-bp del | 622 | ET |
5502-5 | 44/F | CRT 52-bp del | 441 | ET |
8744 | 75/M | CRT 4-bp del | 559 | ET |
1526 | 75/F | CRT 52-bp del | 270 | ET |
6105 | 31/F | CRT 52-bp del | 341 | ET |
2648-2 | 70/M | CRT 52-bp del | 389 | ET |
2648-3 | 70/M | CRT 52-bp del | 399 | ET |
6102 | 34/M | CRT 52-bp del | 312 | PMF |
4995-2 | 45/F | CRT 5-bp ins | 300 | ET |
3829 | 48/M | CRT 52-bp del | 738 | ET |
7245 | 30/F | CRT 52-bp del | 433 | ET |
8742 | 56/F | CRT 52-bp del | 178 | PMF |
8251-2 | 72/F | CRT 5-bp ins | 558 | PMF |
1718 | 81/F | CRT 52-bp del | 261 | PMF |
2791-1 | 62/M | CRT 52-bp del | 91 | Post-ET MF |
1521 | 78/M | CRT 52-bp del | 273 | MF |
2028-1 | 59/M | CRT 52-bp del | 400 | Post-ET MF |
1244 | 71/M | JAK2V617F | 98 | PMF |
9813 | 84/M | JAK2V617F | 420 | PMF |
2161 | 48/M | JAK2V617F | 422 | PV |
4493 | 69/F | JAK2V617F | 172 | Post-PV MF |
2791-4 | 64/M | CRT 52-bp del | 68 | Post-ET MF |
7313-1 | 61/M | CRT 5-bp ins | 139 | MF |
For some patients, multiple blood collections on different dates were used for this study. These are indicated by hyphens and the internal blood collection number following the patient ID number. del, deletion; F, female; ins, insertion; M, male.